Dr. Yeung’s research includes both basic science and translational studies, and spans from the determination of molecular mechanisms of altered drug metabolism using 3-dimensional cell culture techniques to the evaluation of the effect of drugs and nutritional supplements on health outcomes in patients receiving hemodialysis. She is also involved in the development of a “kidney on a chip” microphysiological system that can be used in preclinical drug toxicity screening.
She is a content scientist with the UW Department of Pharmaceutics’ Metabolism and Transport Drug Interaction Database. Cathy is the recipient of a National Institutes of Health/National Center for Advancing Translational Sciences KL2 Multidisciplinary Career Development Award and a Coplon Extramural Grant (Satellite Healthcare Foundation) for promising kidney researchers. She is committed to improving drug safety and optimizing medication selection and dosing based on genetics and disease progression, and is inspired by the spirit and resilience of kidney disease patients and their families.